开发一种通过肠道微细胞的葡萄糖蛋白2用于癌症免疫治疗的级联向口服疫苗

相关实验视频

Updated: May 26, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Wanqiong Li¹, Xin Yang¹, Mengfan Wang¹

¹School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.

|February 24, 2025

概括

这项研究引入了一种新的口服疫苗平台,使用D-针对M细胞和酵母囊来激活CD8+T细胞. 这种方法通过刺激综合免疫反应来增强癌症免疫疗法和传染病预防.

科学领域:

免疫学免疫学免疫学
疫苗学疫苗学疫苗学
生物技术是生物技术.

背景情况:

肠关联淋巴组织 (GALT),特别是皮耶斑块 (PPs),含有微 (M) 细胞和树突细胞 (DCs),对于口服疫苗的疗效至关重要.
特定的受体,如M细胞上的葡萄糖蛋白2 (GP2) 和DC细胞上的甲基-1是增强抗原吸收的关键目标.

研究的目的:

为改善癌症免疫疗法和预防传染病开发一种新型的级联向口服疫苗平台.
为了利用特定的M细胞和DC向,实现高效的抗原递送和免疫激活.

主要方法:

菌体显示查发现了一种耐胃肠道水解的D- (^DGPBP-2(1-8) 向M细胞上的GP2受体.
D-与含β-葡萄糖的酵母囊 (GP2-YCs) 结合,以创建一个双准系统.

主要成果:

GP2-YCs成功地促进了肠道M细胞的抗原交叉,并通过底层的DCs进行了随后的内细胞分裂.
口服疫苗激活了CD8+ T细胞,引发了强大的细胞,幽默和粘膜免疫反应.

结论:

开发的级联向口服疫苗平台显示了癌症免疫治疗的巨大潜力.
该平台通过诱导广泛的免疫反应,为预防传染病提供了一个有前途的战略.

关键词:

癌症免疫疗法免疫疗法甘氨酸蛋白 2 2 的使用.肠道微细胞的细胞是什么口服疫苗是口服的疫苗.这是一种类.

更多相关视频

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...